GILEAD SCIENCES, INC. Selling, General and Administrative Expense
GILEAD SCIENCES, INC. (GILD) reported Selling, General and Administrative Expense of $1.92 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- GILEAD SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.92B, a 40.73% increase year-over-year.
- GILEAD SCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.45B, a 15.34% increase year-over-year.
- GILEAD SCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.79B, a 5.93% decline year-over-year.
- GILEAD SCIENCES, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.36B, a 5.30% decline year-over-year.
- GILEAD SCIENCES, INC. selling, general and administrative expense for fiscal 2025 was $5.77B, a 5.20% decline from fiscal 2024.
- GILEAD SCIENCES, INC. selling, general and administrative expense for fiscal 2024 was $6.09B, a 0.02% increase from fiscal 2023.
- GILEAD SCIENCES, INC. selling, general and administrative expense for fiscal 2023 was $6.09B, a 7.35% increase from fiscal 2022.
- GILEAD SCIENCES, INC. selling, general and administrative expense for fiscal 2022 was $5.67B, a 8.14% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.92B 10-Q · filed 2026-08-06 | $3.37B 10-Q · filed 2026-08-06 | $5.17B derived: sum of 3 quarters · filed 2026-08-06 | $6.52B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.45B 10-Q · filed 2026-05-07 | $3.25B derived: sum of 2 quarters · filed 2026-05-07 | $4.60B derived: sum of 3 quarters · filed 2026-05-07 | $5.97B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.79B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.15B derived: sum of 2 quarters · filed 2026-02-24 | $4.52B derived: sum of 3 quarters · filed 2026-08-06 | $5.77B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $1.36B 10-Q · filed 2025-11-07 | $2.72B derived: sum of 2 quarters · filed 2026-08-06 | $3.98B 10-Q · filed 2025-11-07 | $5.89B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.36B 10-Q · filed 2026-08-06 | $2.62B 10-Q · filed 2026-08-06 | $4.53B derived: sum of 3 quarters · filed 2026-08-06 | $5.96B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.26B 10-Q · filed 2026-05-07 | $3.17B derived: sum of 2 quarters · filed 2026-05-07 | $4.60B derived: sum of 3 quarters · filed 2026-05-07 | $5.97B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.91B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.34B derived: sum of 2 quarters · filed 2026-02-24 | $4.72B derived: sum of 3 quarters · filed 2026-02-24 | $6.09B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $1.43B 10-Q · filed 2025-11-07 | $2.81B derived: sum of 2 quarters · filed 2025-11-07 | $4.18B 10-Q · filed 2025-11-07 | $5.79B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $1.38B 10-Q · filed 2025-08-07 | $2.75B 10-Q · filed 2025-08-07 | $4.36B derived: sum of 3 quarters · filed 2026-02-24 | $5.67B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $1.38B 10-Q · filed 2025-05-07 | $2.98B derived: sum of 2 quarters · filed 2026-02-24 | $4.30B derived: sum of 3 quarters · filed 2026-02-24 | $6.15B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $1.61B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.92B derived: sum of 2 quarters · filed 2026-02-24 | $4.77B derived: sum of 3 quarters · filed 2026-02-24 | $6.09B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $1.31B 10-Q · filed 2024-11-12 | $3.16B derived: sum of 2 quarters · filed 2024-11-12 | $4.48B 10-Q · filed 2024-11-12 | $6.50B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $1.85B 10-Q · filed 2024-08-08 | $3.17B 10-Q · filed 2024-08-08 | $5.19B derived: sum of 3 quarters · filed 2025-02-28 | $6.40B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $1.32B 10-Q · filed 2024-05-08 | $3.34B derived: sum of 2 quarters · filed 2025-02-28 | $4.55B derived: sum of 3 quarters · filed 2025-02-28 | $5.91B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $2.02B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.23B derived: sum of 2 quarters · filed 2025-02-28 | $4.59B derived: sum of 3 quarters · filed 2025-02-28 | $5.67B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $1.21B 10-Q · filed 2023-11-07 | $2.57B derived: sum of 2 quarters · filed 2023-11-07 | $3.65B 10-Q · filed 2023-11-07 | $5.30B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $1.36B 10-Q · filed 2023-08-04 | $2.44B 10-Q · filed 2023-08-04 | $4.09B derived: sum of 3 quarters · filed 2024-02-23 | $5.28B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $1.08B 10-Q · filed 2023-05-03 | $2.73B derived: sum of 2 quarters · filed 2024-02-23 | $3.92B derived: sum of 3 quarters · filed 2024-02-23 | $5.27B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $1.65B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $2.84B derived: sum of 2 quarters · filed 2024-02-23 | $4.19B derived: sum of 3 quarters · filed 2024-02-23 | $5.25B 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $1.19B 10-Q · filed 2022-11-02 | $2.54B derived: sum of 2 quarters · filed 2022-11-02 | $3.60B 10-Q · filed 2022-11-02 | $5.33B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $1.35B 10-Q · filed 2022-08-08 | $2.41B 10-Q · filed 2022-08-08 | $4.14B derived: sum of 3 quarters · filed 2023-02-22 | $5.24B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $1.05B 10-Q · filed 2022-05-04 | $2.79B derived: sum of 2 quarters · filed 2023-02-22 | $3.89B derived: sum of 3 quarters · filed 2023-02-22 | $5.13B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $1.73B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.84B derived: sum of 2 quarters · filed 2023-02-22 | $4.08B derived: sum of 3 quarters · filed 2023-02-22 | $5.15B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $1.11B 10-Q · filed 2021-11-03 | $2.35B derived: sum of 2 quarters · filed 2021-11-03 | $3.42B 10-Q · filed 2021-11-03 | $4.63B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $1.24B 10-Q · filed 2021-08-05 | $2.31B 10-Q · filed 2021-08-05 | $3.52B derived: sum of 3 quarters · filed 2022-02-23 | $4.57B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $1.08B 10-Q · filed 2021-05-06 | $2.28B derived: sum of 2 quarters · filed 2022-02-23 | $3.33B derived: sum of 3 quarters · filed 2022-02-23 | $4.43B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.26B derived: sum of 2 quarters · filed 2022-02-23 | $3.35B derived: sum of 3 quarters · filed 2022-02-23 | $4.38B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $1.05B 10-Q · filed 2020-11-04 | $2.15B derived: sum of 2 quarters · filed 2020-11-04 | $3.18B 10-Q · filed 2020-11-04 | $4.31B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $1.09B 10-Q · filed 2020-08-06 | $2.13B 10-Q · filed 2020-08-06 | $3.26B derived: sum of 3 quarters · filed 2021-02-25 | $4.20B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $1.03B 10-Q · filed 2020-05-06 | $2.16B derived: sum of 2 quarters · filed 2021-02-25 | $3.11B derived: sum of 3 quarters · filed 2021-02-25 | $4.09B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.08B derived: sum of 2 quarters · filed 2021-02-25 | $3.06B derived: sum of 3 quarters · filed 2021-02-25 | $4.06B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $948.00M 10-Q · filed 2019-11-05 | $1.93B derived: sum of 2 quarters · filed 2019-11-05 | $2.92B 10-Q · filed 2019-11-05 | $4.18B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $980.00M 10-Q · filed 2019-08-06 | $1.98B 10-Q · filed 2019-08-06 | $3.23B derived: sum of 3 quarters · filed 2020-02-25 | $4.11B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $997.00M 10-Q · filed 2019-05-08 | $2.25B derived: sum of 2 quarters · filed 2020-02-25 | $3.13B derived: sum of 3 quarters · filed 2020-02-25 | $4.03B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.13B derived: sum of 2 quarters · filed 2020-02-25 | $3.03B derived: sum of 3 quarters · filed 2020-02-25 | $3.88B 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $879.00M 10-Q · filed 2018-11-06 | $1.78B derived: sum of 2 quarters · filed 2018-11-06 | $2.63B 10-Q · filed 2018-11-06 | $3.62B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $897.00M 10-Q · filed 2018-08-06 | $1.75B 10-Q · filed 2018-08-06 | $2.74B derived: sum of 3 quarters · filed 2019-02-26 | $3.57B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $850.00M 10-Q · filed 2018-05-09 | $1.84B derived: sum of 2 quarters · filed 2019-02-26 | $2.67B derived: sum of 3 quarters · filed 2019-02-26 | $3.56B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $992.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.82B derived: sum of 2 quarters · filed 2019-02-26 | $2.71B derived: sum of 3 quarters · filed 2019-02-26 | $3.40B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $831.00M 10-Q · filed 2017-11-07 | $1.72B derived: sum of 2 quarters · filed 2017-11-07 | $2.41B 10-Q · filed 2017-11-07 | $3.47B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $890.00M 10-Q · filed 2017-08-07 | $1.57B 10-Q · filed 2017-08-07 | $2.64B derived: sum of 3 quarters · filed 2018-02-27 | $3.54B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $685.00M 10-Q · filed 2017-05-10 | $1.75B derived: sum of 2 quarters · filed 2018-02-27 | $2.65B derived: sum of 3 quarters · filed 2018-02-27 | $3.47B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.97B derived: sum of 2 quarters · filed 2018-02-27 | $2.78B derived: sum of 3 quarters · filed 2018-02-27 | $3.43B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $903.00M 10-Q · filed 2016-11-07 | $1.72B derived: sum of 2 quarters · filed 2016-11-07 | $2.36B 10-Q · filed 2016-11-07 | $3.24B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $812.00M 10-Q · filed 2016-08-05 | $1.46B 10-Q · filed 2016-08-05 | $2.33B derived: sum of 3 quarters · filed 2017-02-27 | $3.28B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $645.00M 10-Q · filed 2016-05-06 | $1.52B derived: sum of 2 quarters · filed 2017-02-27 | $2.47B derived: sum of 3 quarters · filed 2017-02-27 | $3.08B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $876.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.82B derived: sum of 2 quarters · filed 2017-02-27 | $2.44B derived: sum of 3 quarters · filed 2017-02-27 | $2.98B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $945.00M 10-Q · filed 2015-11-04 | $944.84M 10-Q · filed 2014-11-05 | $1.56B derived: sum of 2 quarters · filed 2015-11-04 | $2.11B 10-Q · filed 2015-11-04 | $2.11B 10-Q · filed 2014-11-05 | $2.62B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $614.00M 10-Q · filed 2015-08-05 | $613.55M 10-Q · filed 2014-08-04 | $1.16B 10-Q · filed 2015-08-05 | $1.16B 10-Q · filed 2014-08-04 | $1.67B derived: sum of 3 quarters · filed 2016-02-24 | $2.08B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $548.00M 10-Q · filed 2015-05-08 | $548.12M 10-Q · filed 2014-05-07 | $1.06B derived: sum of 2 quarters · filed 2016-02-24 | $1.47B derived: sum of 3 quarters · filed 2016-02-24 | $1.87B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $512.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $919.71M derived: sum of 2 quarters · filed 2016-02-24 | $1.32B derived: sum of 3 quarters · filed 2016-02-24 | $1.70B 10-K · filed 2016-02-24 | $1.70B 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $406.86M 10-Q · filed 2014-11-05 | $811.85M derived: sum of 2 quarters · filed 2014-11-05 | $1.19B 10-Q · filed 2014-11-05 | $1.55B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $404.99M 10-Q · filed 2014-08-04 | $779.29M 10-Q · filed 2014-08-04 | $1.15B derived: sum of 3 quarters · filed 2015-02-25 | $1.46B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $374.30M 10-Q · filed 2014-05-07 | $740.09M derived: sum of 2 quarters · filed 2015-02-25 | $1.06B derived: sum of 3 quarters · filed 2015-02-25 | $1.39B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $365.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $685.37M derived: sum of 2 quarters · filed 2015-02-25 | $1.02B derived: sum of 3 quarters · filed 2015-02-25 | $1.46B 10-K · filed 2015-02-25 | $1.46B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $319.58M 10-Q · filed 2013-10-31 | $652.09M derived: sum of 2 quarters · filed 2013-10-31 | $1.10B 10-Q · filed 2013-10-31 | $1.44B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $332.50M 10-Q · filed 2013-08-01 | $775.63M 10-Q · filed 2013-08-01 | $1.12B derived: sum of 3 quarters · filed 2014-02-25 | $1.42B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $443.12M 10-Q · filed 2013-05-08 | $789.34M derived: sum of 2 quarters · filed 2014-02-25 | $1.09B derived: sum of 3 quarters · filed 2014-02-25 | $1.39B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $346.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $642.15M derived: sum of 2 quarters · filed 2014-02-25 | $946.41M derived: sum of 3 quarters · filed 2014-02-25 | $1.24B 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $295.93M 10-Q · filed 2012-11-06 | $600.20M derived: sum of 2 quarters · filed 2012-11-06 | $895.76M 10-Q · filed 2012-11-06 | $1.18B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $304.27M 10-Q · filed 2012-08-01 | $599.84M 10-Q · filed 2012-08-01 | $880.05M derived: sum of 3 quarters · filed 2013-02-27 | $1.13B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $295.57M 10-Q · filed 2012-05-04 | $575.78M derived: sum of 2 quarters · filed 2013-02-27 | $826.34M derived: sum of 3 quarters · filed 2013-02-27 | $1.07B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $280.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $530.77M derived: sum of 2 quarters · filed 2013-02-27 | $778.77M derived: sum of 3 quarters · filed 2013-02-27 | $1.04B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $250.56M 10-Q · filed 2011-11-04 | $498.56M derived: sum of 2 quarters · filed 2011-11-04 | $764.18M 10-Q · filed 2011-11-04 | $1.02B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $248.01M 10-Q · filed 2011-08-05 | $513.62M 10-Q · filed 2011-08-05 | $767.52M derived: sum of 3 quarters · filed 2012-02-23 | $994.95M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $265.62M 10-Q · filed 2011-05-09 | $519.51M derived: sum of 2 quarters · filed 2012-02-23 | $746.94M derived: sum of 3 quarters · filed 2012-02-23 | $1.01B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $253.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $481.32M derived: sum of 2 quarters · filed 2012-02-23 | $742.74M derived: sum of 3 quarters · filed 2012-02-23 | $946.69M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $227.43M 10-Q · filed 2010-11-08 | $488.84M derived: sum of 2 quarters · filed 2010-11-08 | $692.79M 10-Q · filed 2010-11-08 | $886.45M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $261.41M 10-Q · filed 2010-08-09 | $465.36M 10-Q · filed 2010-08-09 | $659.03M derived: sum of 3 quarters · filed 2011-02-28 | $848.22M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $203.95M 10-Q · filed 2010-05-10 | $397.62M derived: sum of 2 quarters · filed 2011-02-28 | $586.80M derived: sum of 3 quarters · filed 2011-02-28 | $806.34M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $193.66M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $382.85M derived: sum of 2 quarters · filed 2011-02-28 | $602.39M derived: sum of 3 quarters · filed 2011-02-28 | $797.34M 10-K · filed 2011-02-28 | ||||
| 2008-09-30 | $189.19M 10-Q · filed 2009-11-05 | $408.72M derived: sum of 2 quarters · filed 2009-11-05 | $603.68M 10-Q · filed 2009-11-05 | |||||
| 2008-06-30 | $219.53M 10-Q · filed 2009-08-05 | $414.49M 10-Q · filed 2009-08-05 | ||||||
| 2007-12-31 | $705.74M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |